Retatrutide × Synthesis Peptides - Lab Test, May 2026
Kovera Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
Test results
About this test
This independent HPLC lab test confirms Retatrutide 40mg from Synthesis Peptides at 98.861% purity. The analysis was reported by Kovera Labs on May 24, 2026.
Retatrutide is a triple GLP-1/GIP/glucagon receptor agonist researched for its potential role in weight management, metabolic regulation, and glycemic control. A purity level of 98.861% indicates high-grade synthesis with minimal contamination.
The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.